TCL Archive Regorafenib Trial Meets Primary Endpoint; Overall Survival Improved by 29 Percent January 27, 2012
TCL Archive NCI, NCAB o Seek $1.036 billion In ’79; Senate Committee Approves $920 Million for Fiscal ‘78 June 3, 1977
TCL Archive Cetuximab Plus Irinotecan Increases PFS In Metastatic Colorectal Cancer, EPIC Finds April 27, 2007